These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9707816)
1. Our experience in the combined pathogenetic treatment of chronic glomerulonephritis. Dimitrakov D; Kumchev E; Tzekov V; Manev E; Tzvetkova Z; Tilkyan E; Pandeva S; Nikolov D Folia Med (Plovdiv); 1998; 40(2):67-73. PubMed ID: 9707816 [TBL] [Abstract][Full Text] [Related]
2. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis. Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis]. Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216 [TBL] [Abstract][Full Text] [Related]
4. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant]. Ratner MIa; Fedorova ND Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550 [TBL] [Abstract][Full Text] [Related]
5. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis]. Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924 [TBL] [Abstract][Full Text] [Related]
6. The German Glomerulonephritis Therapy Study: 10 years of controlled randomized trials for the treatment of idiopathic glomerulonephritis. Risler T; Braun N; Bach D; Fünfstück R; Grabensee B; Grupp C; Haufe C; Heering P; Keller F; Krämer B; Müller GA; Schollmeyer P; Stein G; Zäuner I Kidney Blood Press Res; 1996; 19(3-4):196-200. PubMed ID: 8887260 [TBL] [Abstract][Full Text] [Related]
7. [Differentiated pathogenetic therapy of glomerulonephritis]. Belovezhdov N Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444 [No Abstract] [Full Text] [Related]
8. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors]. Belovezhdov N Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of low-dose glucocorticoid regimen in association with cyclophosphamide in patients with glomerulonephritis. Hirja AR; Voroneanu L; Siriopol D; Nistor I; Hogas S; Apetrii M; Volovat C; Veisa G; Mititiuc IL; Florea L; Onofriescu M; Covic A Int Urol Nephrol; 2019 Oct; 51(10):1805-1813. PubMed ID: 31385176 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants]. Belovezhdov N Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373 [TBL] [Abstract][Full Text] [Related]
11. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome]. Krasnova TN; Tareeva IE; Shilov EM; Mukhin NA; Miroshnichenko NG Ter Arkh; 1997; 69(6):21-3. PubMed ID: 9297266 [TBL] [Abstract][Full Text] [Related]
13. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis]. Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925 [TBL] [Abstract][Full Text] [Related]
14. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients. Javaugue V; Karras A; Glowacki F; McGregor B; Lacombe C; Goujon JM; Ragot S; Aucouturier P; Touchard G; Bridoux F Am J Kidney Dis; 2013 Oct; 62(4):679-90. PubMed ID: 23759297 [TBL] [Abstract][Full Text] [Related]
15. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453 [TBL] [Abstract][Full Text] [Related]
18. A case of primary Sjögren's syndrome in combination with chronic mesangiocapillary glomerulonephritis and interstitial nephritis. Dimitrakov D; Pandeva S Folia Med (Plovdiv); 1998; 40(1):29-33. PubMed ID: 9630765 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids]. Belovezhdov N Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843 [TBL] [Abstract][Full Text] [Related]
20. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties]. Cagnoli L; G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]